Cargando…

Cardiomyocyte apoptosis contributes to contractile dysfunction in stem cell model of MYH7 E848G hypertrophic cardiomyopathy

Missense mutations in myosin heavy chain 7 (MYH7) are a common cause of hypertrophic cardiomyopathy (HCM), but the molecular mechanisms underlying MYH7-based HCM remain unclear. In this work, we generated cardiomyocytes derived from isogenic human induced pluripotent stem cells to model the heterozy...

Descripción completa

Detalles Bibliográficos
Autores principales:	Loiben, Alexander M., Chien, Wei-Ming, Friedman, Clayton E., Chao, Leslie S-L., Weber, Gerhard, Goldstein, Alex, Sniadecki, Nathan, Murry, Charles E., Yang, Kai-Chun
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Cold Spring Harbor Laboratory 2023
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9900838/ https://www.ncbi.nlm.nih.gov/pubmed/36747800 http://dx.doi.org/10.1101/2023.01.24.525458

Ejemplares similares

Cardiomyocyte Apoptosis Is Associated with Contractile Dysfunction in Stem Cell Model of MYH7 E848G Hypertrophic Cardiomyopathy
por: Loiben, Alexander M., et al.
Publicado: (2023)

Novel Adult-Onset Systolic Cardiomyopathy Due to MYH7 E848G Mutation in Patient-Derived Induced Pluripotent Stem Cells
por: Yang, Kai-Chun, et al.
Publicado: (2018)

Genetic variations of β-MYH7 in hypertrophic cardiomyopathy and dilated cardiomyopathy
por: Tanjore, Reena, et al.
Publicado: (2010)

Mechanistic complexity of contractile dysfunction in hypertrophic cardiomyopathy
por: Regnier, Michael
Publicado: (2018)

Burst-Like Transcription of Mutant and Wildtype MYH7-Alleles as Possible Origin of Cell-to-Cell Contractile Imbalance in Hypertrophic Cardiomyopathy
por: Montag, Judith, et al.
Publicado: (2018)

MYH10 activation rescues contractile defects in arrhythmogenic cardiomyopathy (ACM)
por: García-Quintáns, Nieves, et al.
Publicado: (2023)

Myocardial Deformation Analysis in MYBPC3 and MYH7 Related Sarcomeric Hypertrophic Cardiomyopathy—The Graz Hypertrophic Cardiomyopathy Registry
por: Höller, Viktoria, et al.
Publicado: (2021)

Screening of MYH7 gene mutation sites in hypertrophic cardiomyopathy and its significance
por: Liu, Hui-Ting, et al.
Publicado: (2019)

Intrinsic MYH7 expression regulation contributes to tissue level allelic imbalance in hypertrophic cardiomyopathy
por: Montag, Judith, et al.
Publicado: (2017)

Fibroblast Growth Factor Receptor 1 Signaling in Adult Cardiomyocytes Increases Contractility and Results in a Hypertrophic Cardiomyopathy
por: Cilvik, Sarah N., et al.
Publicado: (2013)

Intrauterine Treatment of a Fetus with Familial Hypertrophic Cardiomyopathy Secondary to MYH7 Mutation
por: Hill, Meghan G., et al.
Publicado: (2015)

Genetic analysis of monoallelic double MYH7 mutations responsible for familial hypertrophic cardiomyopathy
por: Wang, Bo, et al.
Publicado: (2019)

Severe hypertrophic cardiomyopathy in a patient with a homozygous MYH7 gene variant
por: Serra, Walter, et al.
Publicado: (2022)

Generation of human iPSC line from an arrhythmogenic cardiomyopathy patient with a DSP protein-truncating variant
por: Loiben, Alexander, et al.
Publicado: (2023)

Assessment of dynamic cardiac repolarization and contractility in patients with hypertrophic cardiomyopathy
por: Radbill, Andrew E., et al.
Publicado: (2021)

Stochastic allelic expression as trigger for contractile imbalance in hypertrophic cardiomyopathy
por: Montag, Judith, et al.
Publicado: (2020)

Contractility of Induced Pluripotent Stem Cell-Cardiomyocytes With an MYH6 Head Domain Variant Associated With Hypoplastic Left Heart Syndrome
por: Kim, Min-Su, et al.
Publicado: (2020)

Endothelin‐1 Induces Myofibrillar Disarray and Contractile Vector Variability in Hypertrophic Cardiomyopathy–Induced Pluripotent Stem Cell–Derived Cardiomyocytes
por: Tanaka, Atsushi, et al.
Publicado: (2014)

Variation p.R1045H in MYH7 correlated with hypertrophic cardiomyopathy in a Chinese pedigree
por: Zhang, Yan, et al.
Publicado: (2021)

Genotype-Phenotype Correlation in Hypertrophic Cardiomyopathy: New Variant p.Arg652Lys in MYH7
por: Antoniutti, Guido, et al.
Publicado: (2022)

Hypertrophic Cardiomyopathy in Infants from the Perspective of Cardiomyocyte Maturation
por: Seok, Heeyoung, et al.
Publicado: (2021)

Transcriptional bursts and heterogeneity among cardiomyocytes in hypertrophic cardiomyopathy
por: Burkart, Valentin, et al.
Publicado: (2022)

Novel insights on the relationship between T-tubular defects and contractile dysfunction in a mouse model of hypertrophic cardiomyopathy
por: Crocini, C., et al.
Publicado: (2016)

Altered force generation and cell-to-cell contractile imbalance in hypertrophic cardiomyopathy
por: Kraft, Theresia, et al.
Publicado: (2019)

The contribution of mutations in MYH7 to the onset of cardiomyopathy
por: Bollen, I. A. E., et al.
Publicado: (2017)

Successful knock-in of Hypertrophic Cardiomyopathy-mutation R723G into the MYH7 gene mimics HCM pathology in pigs
por: Montag, J., et al.
Publicado: (2018)

Analysis of Contractile Function of Permeabilized Human Hypertrophic Cardiomyopathy Multicellular Heart Tissue
por: Kresin, Nico, et al.
Publicado: (2019)

Effects of Aficamten on cardiac contractility in a feline translational model of hypertrophic cardiomyopathy
por: Sharpe, Ashley N., et al.
Publicado: (2023)

Circulating miR-499a-5p Is a Potential Biomarker of MYH7—Associated Hypertrophic Cardiomyopathy
por: Baulina, Natalia, et al.
Publicado: (2022)

Generation of three induced pluripotent stem cell lines from hypertrophic cardiomyopathy patients carrying MYH7 mutations
por: Cao, Xu, et al.
Publicado: (2021)

The BDNF rs6265 Polymorphism is a Modifier of Cardiomyocyte Contractility and Dilated Cardiomyopathy
por: Raucci, Frank J., et al.
Publicado: (2020)

Electrophysiological and Contractile Effects of Disopyramide in Patients With Obstructive Hypertrophic Cardiomyopathy: A Translational Study
por: Coppini, Raffaele, et al.
Publicado: (2019)

Effect of cellular and extracellular pathology assessed by T1 mapping on regional contractile function in hypertrophic cardiomyopathy
por: Swoboda, Peter P., et al.
Publicado: (2017)

Phenotypic diversity identified by cardiac magnetic resonance in a large hypertrophic cardiomyopathy family with a single MYH7 mutation
por: Wang, Jie, et al.
Publicado: (2018)

MYH7 p.(Arg1712Gln) is pathogenic founder variant causing hypertrophic cardiomyopathy with overall relatively delayed onset
por: Marsili, Luisa, et al.
Publicado: (2023)

Increased Postnatal Cardiac Hyperplasia Precedes Cardiomyocyte Hypertrophy in a Model of Hypertrophic Cardiomyopathy
por: Farrell, Emily T., et al.
Publicado: (2017)

Upregulation of Cardiomyocyte Ribonucleotide Reductase Increases Intracellular 2 deoxy-ATP, Contractility, and Relaxation
por: Korte, F. Steven, et al.
Publicado: (2011)

Microvascular Dysfunction in Hypertrophic Cardiomyopathy
por: Pelliccia, Francesco, et al.
Publicado: (2022)

Increased Myocardial Oxygen Consumption Precedes Contractile Dysfunction in Hypertrophic Cardiomyopathy Caused by Pathogenic TNNT2 Gene Variants
por: Parbhudayal, Rahana Y., et al.
Publicado: (2020)

Whole-exome sequencing reveals MYH7 p.R671C mutation in three different phenotypes of familial hypertrophic cardiomyopathy
por: Yu, Wei, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_8qit47jh3uedkip6otqu1vl4vf